Concert Pharmaceuticals Inc
NASDAQ:CNCE

Watchlist Manager
Concert Pharmaceuticals Inc Logo
Concert Pharmaceuticals Inc
NASDAQ:CNCE
Watchlist
Price: 8.37 USD Market Closed
Updated: May 20, 2024

Concert Pharmaceuticals Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Concert Pharmaceuticals Inc
Other Long-Term Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Concert Pharmaceuticals Inc
NASDAQ:CNCE
Other Long-Term Assets
$1.2m
CAGR 3-Years
-1%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Long-Term Assets
$9.1B
CAGR 3-Years
24%
CAGR 5-Years
51%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Other Long-Term Assets
$4.8B
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
25%
Amgen Inc
NASDAQ:AMGN
Other Long-Term Assets
$9B
CAGR 3-Years
16%
CAGR 5-Years
39%
CAGR 10-Years
19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Long-Term Assets
$2.8B
CAGR 3-Years
49%
CAGR 5-Years
13%
CAGR 10-Years
75%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Long-Term Assets
$3.2B
CAGR 3-Years
55%
CAGR 5-Years
27%
CAGR 10-Years
29%

See Also

What is Concert Pharmaceuticals Inc's Other Long-Term Assets?
Other Long-Term Assets
1.2m USD

Based on the financial report for Dec 31, 2021, Concert Pharmaceuticals Inc's Other Long-Term Assets amounts to 1.2m USD.

What is Concert Pharmaceuticals Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
18%

Over the last year, the Other Long-Term Assets growth was -3%. The average annual Other Long-Term Assets growth rates for Concert Pharmaceuticals Inc have been -1% over the past three years , 18% over the past five years .